Tonix Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.
CEOSeth Lederman
CEOSeth Lederman
Employees81
Employees81
HeadquartersChatham, New Jersey
HeadquartersChatham, New Jersey
Founded2007
Founded2007
Employees81
Employees81
TNXP Key Statistics
Market cap149.07M
Market cap149.07M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume677.37K
Average volume677.37K
High today—
High today—
Low today—
Low today—
Open price$17.00
Open price$17.00
Volume0.00
Volume0.00
52 Week high$130.00
52 Week high$130.00
52 Week low$6.76
52 Week low$6.76
Stock Snapshot
With a market cap of 149.07M, Tonix Pharmaceuticals(TNXP) trades at $16.95. The stock has a price-to-earnings ratio of -0.02.
Tonix Pharmaceuticals(TNXP) stock opened on 2025-11-10 at $17.00. The price climbed to — and dipped to —.
The Tonix Pharmaceuticals(TNXP)'s current trading volume is 0, compared to an average daily volume of 677.37K.
During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $130.00 at its peak.
During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $130.00 at its peak.
TNXP News
TipRanks 6d
Tonix Pharmaceuticals announces collaboration with MGHTonix Pharmaceuticals (TNXP) announced a collaboration with Massachusetts General Hospital, MGH, a founding member of Mass General Brigham, MGB, to conduct a Ph...
People also own
Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.